A carregar...
T24. A PHASE 3, MULTICENTER STUDY TO ASSESS THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF ALKS 3831 IN SUBJECTS WITH SCHIZOPHRENIA
BACKGROUND: ALKS 3831, currently under development for the treatment of schizophrenia, is composed of a flexible dose of olanzapine and a fixed dose of 10 mg of samidorphan. Samidorphan is intended to mitigate weight gain associated with olanzapine treatment alone. Here, we report the safety, tolera...
Na minha lista:
| Publicado no: | Schizophr Bull |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455800/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz019.304 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|